Author(s): ZHAO Yujuan, Department of Respiratory Medicine, The 245 Hospital of Shenyang
Pages: 32-33
Year: 2014 Issue:  5
Journal: Friend of Chemical Industry
Keyword:  Salbutamol combined with mucosolvin; Aerosol inhalation; Senile pneumonia; Prognosis;
Abstract: Objective To analyze and discuss the prognosis of senile pneumonia treated by salbutamol combined with mucosolvin and oxygen-driven aerosol inhalation. Methods 46 cases of patients with senile pneumonia admitted in our hospital from May, 2010 to May, 2013 were randomly selected and divided into the treatment group and the control group with 23 cases in each. Two groups of patients were given antibiotics and other conventional treatment. In addition, the treatment group was given salbutamol combined with mucosolvin and oxygen-driven aerosol inhalation. The efficacy and prognosis were compared between the two groups. Results The significant efficiency of the treatment group was 60.87%, the total effective rate was 95.65%, while that of the control group separately was 30.43% and 86.96%, there was no statistically significant difference between the groups in total effective rate(P>0.05), but the significant efficiency of the treatment group was obviously higher than of the control group(P<0.05). The cough and pulmonary rales disappearing time after the treatment and the length of hospital stay of the control group were obviously longer than those of the treatment group, the differences were significant. Conclusion Salbutamol combined with mucosolvin and oxygen-driven aerosol inhalation is quite effective in the treatment of senile pneumonia and the prognosis of the patients is good, which is worthy of clinical application.